U.S. Markets closed

Why Cynosure (CYNO) Has A Bright Short-Term Future?

Zacks Equity Research

One company that should be on your radar is Cynosure, Inc. (CYNO). The stock of this manufacturer of aesthetic treatment systems has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.  

A key reason for this move has been the positive trend in the earnings estimate revisions picture. For CYNO’s full year estimate, we have seen 1 estimate move higher in the past 30 days, compared to none moving lower. This trend has helped the consensus estimate to trend higher, going from $1.31 per share a month ago to its current level at $1.42.

This positive shift in estimates has made some investors take notice and buy the stock. In fact, CYNO has seen some pretty solid trading lately, as the company has moved higher by almost 10.5% in the past month.

If Cynosure can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put CYNO on your watch list for the future.       

Other top-ranked stocks worth considering in this space include Natus Medical Inc. (BABY), ABIOMED, Inc. (ABMD) and AngioDynamics Inc. (ANGO). While Natus Medical sports a Zacks Rank #1 (Strong Buy), ABIOMED and AngioDynamics holds a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CYNOSURE INC (CYNO): Free Stock Analysis Report

NATUS MEDICAL INC (BABY): Free Stock Analysis Report

ABIOMED INC (ABMD): Free Stock Analysis Report

ANGIODYNAMICS INC (ANGO): Free Stock Analysis Report

Zacks Investment Research